Kura Oncology (NASDAQ:KURA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Kura Oncology (KURA) operate in?

Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kura Oncology Stock (NASDAQ: KURA) stock price, news, charts, stock research, profile.

Open	$20.00
Close	$20.01
Volume / Avg.	314.31K / 749.64K
Day Range	19.83 - 20.19
52 Wk Range	7.41 - 24.17
Market Cap	$1.60B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	13.05%
Days to Cover	16.59

Recent News

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

Avi Kapoor

Why Cancer-Drug Developer Kura Oncology Stock Is Up

Kura Oncology, Inc. shares are trading higher Tuesday after the company reported preliminary clinical data from the first 20 patients its Komet-007 Phase 1 dose-escalation trial. Kura reported that all newly diagnosed patients treated with ziftomenib and 7+3 achieved a complete remission (CR) with full count recovery, for a CR rate of 100% (5/5), including four patients with NPM1-m acute myeloid leukemia (AML) and one patient with KMT2A-r AML.

Erica Kollmann

General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded slightly lower, with the Dow Jones falling around 20 points on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Kura Oncology Inc

Sector

Health Care

Industry

Biotechnology

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and dev...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kura Oncology (KURA) stock?

You can purchase shares of Kura Oncology (NASDAQ:KURA) through any online brokerage.

View our list of the best stock brokerages

Who are Kura Oncology (KURA) competitors?

Other companies in Kura Oncology’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Immatics (NASDAQ:IMTX), Kiniksa Pharmaceuticals (NASDAQ:KNSA), Bicycle Therapeutics (NASDAQ:BCYC) and Nurix Therapeutics (NASDAQ:NRIX).

What is the target price for Kura Oncology (KURA) stock?

There is no analysis for Kura Oncology.

What is the forecast for Kura Oncology (KURA) stock?

Kura Oncology has a consensus price target of $28.63.

Current stock price for Kura Oncology (KURA)?

The stock price for Kura Oncology (NASDAQ: KURA) is $21.01 last updated July 5, 2024 at 7:13 PM EDT.

Does Kura Oncology (KURA) pay a dividend?

There are no upcoming dividends for Kura Oncology.

When is Kura Oncology (NASDAQ:KURA) reporting earnings?

Kura Oncology’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Kura Oncology (KURA) going to split?

There is no upcoming split for Kura Oncology.

What sector and industry does Kura Oncology (KURA) operate in?

Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Kura Oncology

Kura Oncology (KURA) Forecast